Literature DB >> 26178429

Molecular genetics and pathogenesis of cardiomyopathy.

Akinori Kimura1.   

Abstract

Cardiomyopathy is defined as a disease of functional impairment in the cardiac muscle and its etiology includes both extrinsic and intrinsic factors. Cardiomyopathy caused by the intrinsic factors is called as primary cardiomyopathy of which two major clinical phenotypes are hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Genetic approaches have revealed the disease genes for hereditary primary cardiomyopathy and functional studies have demonstrated that characteristic functional alterations induced by the disease-associated mutations are closely related to the clinical types, such that increased and decreased Ca(2+) sensitivities of muscle contraction are associated with HCM and DCM, respectively. In addition, recent studies have suggested that mutations in the Z-disc components found in HCM and DCM may result in increased and decreased stiffness of sarcomere, respectively. Moreover, functional analysis of mutations in the other components of cardiac muscle have suggested that the altered response to metabolic stresses is associated with cardiomyopathy, further indicating the heterogeneity in the etiology and pathogenesis of cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26178429     DOI: 10.1038/jhg.2015.83

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  144 in total

Review 1.  Restrictive cardiomyopathy.

Authors:  S S Kushwaha; J T Fallon; V Fuster
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

2.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

3.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

Authors:  H Watkins; A Rosenzweig; D S Hwang; T Levi; W McKenna; C E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

4.  Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene.

Authors:  M Satoh; M Takahashi; T Sakamoto; M Hiroe; F Marumo; A Kimura
Journal:  Biochem Biophys Res Commun       Date:  1999-08-27       Impact factor: 3.575

5.  A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.

Authors:  C Semsarian; M J Healey; D Fatkin; M Giewat; C Duffy; C E Seidman; J G Seidman
Journal:  J Mol Cell Cardiol       Date:  2001-11       Impact factor: 5.000

6.  Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Brenda Gerull; Arnd Heuser; Thomas Wichter; Matthias Paul; Craig T Basson; Deborah A McDermott; Bruce B Lerman; Steve M Markowitz; Patrick T Ellinor; Calum A MacRae; Stefan Peters; Katja S Grossmann; Jörg Drenckhahn; Beate Michely; Sabine Sasse-Klaassen; Walter Birchmeier; Rainer Dietz; Günter Breithardt; Eric Schulze-Bahr; Ludwig Thierfelder
Journal:  Nat Genet       Date:  2004-10-17       Impact factor: 38.330

7.  Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations.

Authors:  Manuel Hermida-Prieto; Lorenzo Monserrat; Alfonso Castro-Beiras; Rafael Laredo; Rafaela Soler; Jesus Peteiro; Esther Rodríguez; Beatriz Bouzas; Nemesio Alvarez; Javier Muñiz; Marisa Crespo-Leiro
Journal:  Am J Cardiol       Date:  2004-07-01       Impact factor: 2.778

8.  Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy.

Authors:  Takuro Arimura; Takeharu Hayashi; Yuji Matsumoto; Hiroki Shibata; Shitoshi Hiroi; Takeyuki Nakamura; Natsuko Inagaki; Kunihiko Hinohara; Megumi Takahashi; Satoh-Itoh Manatsu; Taishi Sasaoka; Toru Izumi; Gisèle Bonne; Ketty Schwartz; Akinori Kimura
Journal:  Biochem Biophys Res Commun       Date:  2007-03-30       Impact factor: 3.575

9.  Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies.

Authors:  Takuro Arimura; Anne Helbling-Leclerc; Catherine Massart; Shaida Varnous; Florence Niel; Emmanuelle Lacène; Yves Fromes; Marcel Toussaint; Anne-Marie Mura; Dagmar I Keller; Helge Amthor; Richard Isnard; Marie Malissen; Ketty Schwartz; Gisèle Bonne
Journal:  Hum Mol Genet       Date:  2004-11-17       Impact factor: 6.150

10.  Tnni3k modifies disease progression in murine models of cardiomyopathy.

Authors:  Ferrin C Wheeler; Hao Tang; Odessa A Marks; Tracy N Hadnott; Pei-Lun Chu; Lan Mao; Howard A Rockman; Douglas A Marchuk
Journal:  PLoS Genet       Date:  2009-09-18       Impact factor: 5.917

View more
  43 in total

1.  Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.

Authors:  Claudia T Flynn; Taishi Kimura; Kwesi Frimpong-Boateng; Stephanie Harkins; J Lindsay Whitton
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

2.  A Restrictive Cardiomyopathy Mutation in an Invariant Proline at the Myosin Head/Rod Junction Enhances Head Flexibility and Function, Yielding Muscle Defects in Drosophila.

Authors:  Madhulika Achal; Adriana S Trujillo; Girish C Melkani; Gerrie P Farman; Karen Ocorr; Meera C Viswanathan; Gaurav Kaushik; Christopher S Newhard; Bernadette M Glasheen; Anju Melkani; Jennifer A Suggs; Jeffrey R Moore; Douglas M Swank; Rolf Bodmer; Anthony Cammarato; Sanford I Bernstein
Journal:  J Mol Biol       Date:  2016-04-20       Impact factor: 5.469

Review 3.  Diseases of the Nucleoskeleton.

Authors:  James M Holaska
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

Review 4.  At the heart of inter- and intracellular signaling: the intercalated disc.

Authors:  Heather R Manring; Lisa E Dorn; Aidan Ex-Willey; Federica Accornero; Maegen A Ackermann
Journal:  Biophys Rev       Date:  2018-06-06

5.  A missense variant in the titin gene in Doberman pinscher dogs with familial dilated cardiomyopathy and sudden cardiac death.

Authors:  Kathryn M Meurs; Steven G Friedenberg; Justin Kolb; Chandra Saripalli; Paola Tonino; Kathleen Woodruff; Natasha J Olby; Bruce W Keene; Darcy B Adin; Oriana L Yost; Teresa C DeFrancesco; Sunshine Lahmers; Sandra Tou; G Diane Shelton; Henk Granzier
Journal:  Hum Genet       Date:  2019-02-04       Impact factor: 4.132

Review 6.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Authors:  Ali J Marian; Eugene Braunwald
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

Review 7.  Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.

Authors:  Ali J Marian; Eva van Rooij; Robert Roberts
Journal:  J Am Coll Cardiol       Date:  2016-12-27       Impact factor: 24.094

8.  Interaction between cardiac myosin-binding protein C and formin Fhod3.

Authors:  Sho Matsuyama; Yohko Kage; Noriko Fujimoto; Tomoki Ushijima; Toshihiro Tsuruda; Kazuo Kitamura; Akira Shiose; Yujiro Asada; Hideki Sumimoto; Ryu Takeya
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-23       Impact factor: 11.205

9.  Genetic background of Japanese patients with pediatric hypertrophic and restrictive cardiomyopathy.

Authors:  Takeharu Hayashi; Kousuke Tanimoto; Kayoko Hirayama-Yamada; Etsuko Tsuda; Mamoru Ayusawa; Shinichi Nunoda; Akira Hosaki; Akinori Kimura
Journal:  J Hum Genet       Date:  2018-06-15       Impact factor: 3.172

10.  Phenotypic expression of a novel desmin gene mutation: hypertrophic cardiomyopathy followed by systemic myopathy.

Authors:  Haruhito Harada; Takeharu Hayashi; Hirofumi Nishi; Ken Kusaba; Yoshinori Koga; Yasutoshi Koga; Ikuya Nonaka; Akinori Kimura
Journal:  J Hum Genet       Date:  2017-11-22       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.